Redcare Pharmacy NV
XETRA RDC.DE
Redcare Pharmacy NV EBITDA for the year ending December 31, 2023: USD 64.21 M
Redcare Pharmacy NV EBITDA is USD 64.21 M for the year ending December 31, 2023, a 295.84% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
-
Redcare Pharmacy NV EBITDA for the year ending December 31, 2022 was USD -32.79 M, a 23.02% change year over year.
-
Redcare Pharmacy NV EBITDA for the year ending December 31, 2021 was USD -42.59 M, a -337.85% change year over year.
-
Redcare Pharmacy NV EBITDA for the year ending December 31, 2020 was USD 17.91 M, a 180.46% change year over year.
-
Redcare Pharmacy NV EBITDA for the year ending December 31, 2019 was USD -22.26 M, a -19.09% change year over year.
Key data
| Date | EBITDA | Net Income | EPS (Diluted) | Shares (Diluted, Weighted) |
|---|
Market news
Loading...
XETRA: RDC.DE
| CEO | Mr. Olaf Heinrich |
| IPO Date | Aug. 9, 2017 |
| Location | Netherlands |
| Headquarters | Erik de Rodeweg 11–13 |
| Employees | 1,725 |
| Sector | Health Care |
| Industries | |
Description
Redcare Pharmacy NV owns and operates online pharmacies in Germany, Austria, Switzerland, France, Belgium, Italy, and the Netherlands. It provides prescription medications, over-the-counter medications, and pharmacy-related beauty and personal care products, as well as food supplements. The company was formerly known as Shop Apotheke Europe N.V. and changed its name to Redcare Pharmacy NV in June 2023. The company was founded in 2001 and is headquartered in Sevenum, the Netherlands.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email